Renalytix plc Quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax in USD from Q2 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
Summary
Renalytix plc quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax history and growth rate from Q2 2018 to Q1 2024.
  • Renalytix plc Accumulated Other Comprehensive Income (Loss), Net of Tax for the quarter ending March 31, 2024 was -$1.56M, a 85.7% decline year-over-year.
Accumulated Other Comprehensive Income (Loss), Net of Tax, Quarterly (USD)
Accumulated Other Comprehensive Income (Loss), Net of Tax, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$1.56M -$719K -85.7% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$1.73M +$203K +10.5% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 -$1.33M +$272K +16.9% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$1.45M -$535K -58.5% Jun 30, 2023 10-Q 2024-05-15
Q1 2023 -$839K -$4M -127% Mar 31, 2023 6-K 2023-06-09
Q4 2022 -$1.94M -$7.73M -133% Dec 31, 2022 6-K 2023-03-30
Q3 2022 -$1.61M Sep 30, 2022 6-K 2022-11-30
Q2 2022 -$915K -$9.19M -111% Jun 30, 2022 10-K 2023-09-28
Q1 2022 $3.16M Mar 31, 2022 6-K 2022-06-30
Q4 2021 $5.79M Dec 31, 2021 6-K/A 2022-04-29
Q2 2021 $8.28M +$9.48M Jun 30, 2021 20-F 2022-10-31
Q2 2020 -$1.2M -$378K -46% Jun 30, 2020 20-F/A 2022-08-01
Q2 2019 -$822K -$826K -20650% Jun 30, 2019 20-F/A 2022-08-01
Q2 2018 $4K Jun 30, 2018 20-F/A 2020-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.